SCHEMBL6098562

SCHEMBL6098562

CC(C)CCC(N1CCCC(N(C)Cc2ccccc2)C1)S(=O)(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.43
RORC P51449 14/20 0.42
POLB P06746 1/20 0.41
AGTR2 P50052 2/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6096866 0.82 HRH3 (0.42) KMT2A
SCHEMBL6099133 0.80 CHRM2 (0.39) RORCAGTR2
SCHEMBL8258573 0.79 KMT2A (0.49) KMT2AAGTR2
SCHEMBL6097057 0.79 RORC (0.41) RORCHSD17B10
SCHEMBL6095467 0.79 RORC (0.46) KMT2ARORCHSD17B10
SCHEMBL6098385 0.78 CASP3 (0.38) KMT2ARORCPOLBAGTR2HPGD
SCHEMBL6098125 0.77 FABP6 (0.36) RORC
SCHEMBL6097505 0.77 RORC (0.34) KMT2ARORCHSD17B10
SCHEMBL6097882 0.77 RORC (0.34) KMT2ARORCHSD17B10
SCHEMBL6095436 0.77 CYP2C19 (0.41) KMT2ARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040229864-A1 Sulfone derivatives as 5-HT7 receptor ligands MERCK SHARP & DOHME LTD. (GB) 2004-11-18 US claimed
US-7101892-B2 Sulfone derivatives as 5-HT7 receptor ligands MERCK SHARP & DOHME LTD. 2006-09-05 US disclosed
US-20040229864-A1 Sulfone derivatives as 5-HT7 receptor ligands MERCK SHARP & DOHME LTD. (GB) 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229864-A1 Sulfone derivatives as 5-HT7 receptor ligands HTR7, HTR2C, HTR1A KMT2A 2168/4885RORC 669/4885POLB 4156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.